Skip to main content
Collection

UKHSA evidence reviews

Evidence reviews conducted by the All Hazards Public Health Response Evidence Review team and the Science Evidence Review team within UKHSA.

Updates to this page

From:
UK Health Security Agency
Published:
25 March 2023
Last updated:
8 September 2026
Show all updates

  1. Added 'Characteristics of people infected with toxigenic C. ulcerans' under heading Other infections.

  2. Added 5 new Meningococcal disease evidence reviews.

  3. Added 'Hand hygiene alternatives to soap and water for reducing C. difficile' under heading Clostridioides difficile.

  4. Added 'Health impacts of emissions from incinerators: UKHSA opinion of the evidence' to Environmental Hazards collection.

  5. Added 'Hantavirus: vaccine effectiveness following Andes virus exposure' under heading 'Hantavirus'.

  6. Added 'Hantavirus: human-to-human infection transmission parameters'.

  7. Added 'Viral load variations in people living with HIV on ART' to section 'Other infections'.

  8. Added 'Effectiveness of intervention strategies to increase vaccine uptake' to section 'Other infections'.

  9. Added 2 new evidence reviews under heading Clostridioides difficile: ‘Effectiveness of isolation strategies for people with C. difficile’ and ‘Effectiveness of IPC measures for high prevention of C. difficile’. Moved ‘Clostridioides difficile diagnostic test accuracy’ into this new section.

  10. Added link to 'Healthcare provision at events: a rapid scoping review' page.

  11. Added 'Health emergency planning'.

  12. Added 'Influenza A (H3, H7, H9, H10): incubation and infectious period', 'Influenza A (H3, H5, H7, H9, H10): routes of transmission' and 'Influenza A (H3, H5, H7, H9, H10): asymptomatic and pre-symptomatic transmission'.

  13. Added new heading Public health and social measures: 'Rapid mapping review of PHSM for respiratory pathogens other than COVID-19'.

  14. Added 3 new evidence reviews under heading Tuberculosis: 'Transmission of zoonotic TB from animals to humans', 'Transmission of zoonotic TB from humans to animals' and 'Transmission of zoonotic TB between humans'. Also added one evidence review under heading Staphylococcal infections: 'Antibiotics for the treatment of invasive PVL-SA infection'.

  15. Added 'Public health communication strategies during CBRNe events'

  16. Added 3 new evidence reviews under heading Staphylococcal infections: 'Decolonisation regimes for people infected with Staphylococcal infections', 'Venous thromboembolism in people with invasive PVL-SA infections' and 'Intravenous immunoglobulin for the treatment of invasive PVL-SA'.

  17. Added link to 'Oropouche virus: a rapid evidence gap map'.

  18. Added 'Doxycycline: serious or severe adverse effects'.

  19. Added 'Argentine haemorrhagic fever'.

  20. Added 5 new evidence reviews under heading Staphylococcal infections: 'Decontamination for prevention of PVL-SA infections', 'Decolonisation regimes for people infected with PVL-SA', 'Decontamination for prevention of Staphylococcal infections', 'PVL-SA associated pneumonia: antibiotic effectiveness' and 'PVL-SA associated bacteraemia: antibiotic effectiveness'. Added 2 new evidence reviews under heading Tuberculosis: 'Identifying tuberculosis in prisons and places of detention' and 'Identifying tuberculosis in people seeking asylum'.

  21. Added 'Influenza A (H1N1pdm09)'

  22. Added 3 new evidence reviews 'Mpox incubation and infectious periods', 'Mpox asymptomatic and pre-symptomatic transmission' and 'Mpox routes of transmission'. Also added 'Mpox: adherence and barriers to isolation'.

  23. Moved environmental hazards section to the top.

  24. Added environmental hazards section.

  25. Added 'Clostridioides difficile diagnostic test accuracy' and 'Vaginal oestrogen for prevention of primary urinary tract infections' to Other infections.

  26. Added 'Influenza A (H5)', 'Influenza A (H5) in non-human mammals' and 'Influenza A (H5 or H7) and conjunctivitis'.

  27. Added 'Influenza A (H1N1v and H1N2v)'.

  28. Added 'Interventions to reduce harms for people who inject drugs in prisons'

  29. Added climate change and health equity review.

  30. Added 'Communal accommodation settings'.

  31. Added 'Communal accommodation settings'.

  32. Added 'Chapare virus'.

  33. Added The global epidemiology of sporotrichosis: A rapid review.

  34. Added COVID-19: non-pharmaceutical interventions to reduce transmission.

  35. Added Tuberculosis (TB): prevalence of latent infection.

  36. Added evidence reviews conducted during the COVID-19 pandemic by the COVID-19 rapid evidence service.

  37. Added 'COVID-19: effectiveness of N95 masks in community settings' and 'COVID-19 Omicron variant: infectious period and asymptomatic and symptomatic transmission'.

  38. First published.

Meningococcal disease

Hantavirus

Clostridioides difficile

Emergency preparedness and response

Influenza

Public health and social measures

Staphylococcal infections

Tuberculosis

Mpox

Environmental hazards

Health equity and inclusion health

Climate change

COVID-19

Other infections

Contents